Filling the need for trusted information on national health issues
Filling the need for trusted information on national health issues
At a June 3 hearing of the Senate Special Committee on Aging, Diane Rowland, Executive Vice President of the Kaiser Family Foundation and Executive Director on the Kaiser Commission on Medicaid and the Uninsured, testified on the key challenges to providing a larger role for private long-term care insurance in…
Sen. Max Baucus (D-Mont.), chairman of the Senate Committee on Finance, appeared as the first guest in a new series of Health Care Reform newsmaker briefings sponsored by the Kaiser Family Foundation, Families USA and the National Federation of Independent Business. The reporters-only briefings, designed to inform the public about…
This briefing provided an overview of the Medicaid program and its role in the health care system. Panelists discussed who is eligible for Medicaid, what benefits are covered, how the program is administered. Medicaid financing and the program’s role in health reform was also explained. More information on Medicaid from…
The Alliance for Health Reform and the Kaiser Family Foundation present a November 16 briefing to discuss the components of this key policy crossroads with a particular emphasis on the implications for health programs and the health care industry. Automatic cuts would not apply to Medicaid, but Medicare providers would…
Foundation Senior Vice President Tricia Neuman testified Feb. 26, 2013 before the House Ways & Means Subcommittee on Health about how restructuring Medicare’s deductibles and other cost-sharing requirements could affect beneficiaries. Testimony (.pdf)
Recent guidelines are all recommending that HIV treatment be started at a higher CD4 count because of issues such as the ongoing damage caused by HIV itself, and prevention of transmission. Issues in long-term treatment, such as potential side effects, the development of resistance, the cost and sustainability of programmes in resource-poor settings, are some of the potential problems for such a strategy.
The success of highly active antiretroviral therapy, HAART, has been evident for 15 years. Such long-term therapy can have complications though, especially when compounded by co-morbid conditions such as ageing and smoking.
The quality of the available public services which provide medical and social support are far from meeting the needs of injecting drug users (IDUs) and people living with HIV (PLHIV).
This session will examine how leaders from key populations have made a difference by being involved. It will look at selected examples of how their meangful involvement in AIDS policy and programme design has improved the AIDS response, from advocating to change counter productive policies and laws such as criminalization of behavior, to ensuring that universal access targets, AIDS strategies, programmes and monitoring and evaluation systems take into consideration their realities and needs.
Too many young people are living with or otherwise affected by HIV.